|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00673 CHINA HEALTH
Nominal 
0.500 +0.005 (+1.010%) | 2025/03 - Final HKD(K$) | %Chg (Compare to Final) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | |
| Turnover | 38,943 | -35.019% | 59,930 | 76,414 | 107,025 | 87,889 |
| Cost of Sales | (29,708) | -35.825% | (46,292) | (49,222) | (78,336) | (61,897) |
| Gross Profit | 9,235 | -32.285% | 13,638 | 27,192 | 28,689 | 25,992 |
| 2025/03 - Final HKD(K$) | %Chg (Compare to Final) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (17,642) | -4.302% | (18,435) | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | (4,000) | 0 | 0 | |
| Profit / (Loss) before Taxation | (67,378) | 59.309% | (42,294) | (39,383) | (8,709) | (5,331) | |
| Taxation | (443) | 118.227% | (203) | (177) | (405) | (1,228) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 31 | -98.658% | 2,310 | (2,486) | (3,091) | (1,185) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (67,790) | 68.686% | (40,187) | (42,046) | (12,205) | (7,744) | |
| 2025/03 - Final HKD(K$) | %Chg (Compare to Final) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | |
| Net Finance Costs / (Income) | 243 | -- | (593) | 1,754 | (40) | (4,849) |
| Depreciation & Amortisation | 3,412 | -24.978% | 4,548 | 4,152 | 4,031 | 3,571 |
| Directors' Emoluments | 4,040 | 24.845% | 3,236 | 3,251 | 4,240 | 5,184 |
| 2025/03 - Final | %Chg (Compare to Final) | 2024/03 | 2023/03 | 2022/03 | 2021/03 | |
| Auditor's Opinion Status | Disclaimer | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/03 - Final | %Chg (Compare to Final) | 2024/03 | 2023/03 | 2022/03 | 2021/03 | |
| EPS (cts) | -11.140 | 64.615% | -6.767 | -7.896 | -2.370 | -1.522 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.014) | -- | (0.013) | (0.046) | 0.077 | (0.022) |
| NBV per share ($) | (0.012) | -- | 0.087 | 0.144341 | 0.145171 | 0.183846 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -67,790 |
| %Change | 68.686% |
| EPS / (LPS) | HKD -0.111 |
| NBV Per Share ($) | HKD -0.012 |